Lv3
318 积分 2024-11-22 加入
An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)
6小时前
待确认
Serial PNA-Transformer-Based Virtual Screening Identifies Nanomolar DYRK1A Inhibitors for Pancreatic Ductal Adenocarcinoma
6小时前
已完结
Molecular Generation for CNS Drug Discovery and Design
15天前
已完结
Enzyme−Targeted Therapeutics for Neurological Disorders
15天前
已完结
Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 Inhibitors
29天前
已完结
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson’s Disease
29天前
已完结
From Structure to Selectivity: Integrating CADD and AIDD in Rational Medicinal Chemistry Strategies for DYRK1A Inhibitor Discovery
1个月前
已完结
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
1个月前
已完结
Identification and Validation of an Inhibitor of the Protein Kinases PIM and DYRK
1个月前
已完结
Studies directed towards the total synthesis of vancomycin : Formation of biphenyl ether by macrocyclisation
3个月前
已完结
皖公网安备34019202002308
